Skip to main content
. 2016 Nov 25;4(4):654–660. doi: 10.3889/oamjms.2016.125

Table 1.

Clinical characteristic according to age: non-old group (< 65 y), young-old-group (65-74 y) and of the middle-old group (75-84 y)

Mean (sd2) Non-Old (n = 141) Young-Old (n = 128) Middle-Old (n = 57) P value
Age 52.99 (8.57) 69.21 (2.85) 78.49 (2.61) NA1
Body Mass Index 28.34 (5.29) 29.12 (5.97) 28.29 (4.89) 0.79
Ergometry VO2 Max: ml/kg/min 26,09 (9,55) 21.30 (9.91) 14.42 (5.55) <0.01
Ergospirometry VO2 Max: ml/kg/min 20,47 (6,33) 17.18 (4.76) 14.02 (6.06) <0.01
Prevalence at baseline (%)
Gender Male 77 (54.6%) 54 (57.8%) 29 (50.9%) 0.66
Heart Failure 30 (21.3%) 33 (25.8%) 13 (22.8%) 0.64
Coronary Artery Disease 111 (78,7%) 98 (76.6%) 41 (71.9%) 0.32
Acute Myocardial Infarction 68 (48,2%) 44 (34.4%) 20 (35.1%) 0.03
CABG3 36 (25.5%) 40 (31.3%) 12 (21.1%) 0.82
PTCA4 with stent 46 (32.9%) 34 (26.6%) 22 (38.6%) 0.73
Diabetes 34 (24.1%) 47 (36.7%) 22 (38.6%) 0.01
Hypertension 98 (69.5%) 106 (82.8%) 49 (86%) <0.01
Dyslipidemia 80 (56.7%) 84 (65.6%) 33 (57.9%) 0.56
Smoker Current 22 (15.7%) 19 (14.8%) 3 (2.5%) 0.05
Ex-smoker 57 (40.7%) 40 (31.3%) 21 (36.8%)
Non-smoker 61 (43.6%) 69 (53.9%) 34 (59.6%)

y: years; 1: not applicable; 2: standard deviation; 3: coronary artery bypass grafting; 4: percutaneous transluminal coronary angioplasty.